Management of Generalized Vitiligo in Adolescent with Tofacitinib: Clinical Case
Background. Vitiligo is a depigmenting skin disease characterized by selective loss of melanocytes leading to development of typical white spots. There are various theories on vitiligo etiology: genetic, autoimmune, neurogenic, autoinflammatory, oxidative stress theory, and many others. Generally ac...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2024-11-01
|
| Series: | Вопросы современной педиатрии |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/3612 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839575319312334848 |
|---|---|
| author | Eduard T. Ambarchyan Anastasiya D. Kuzminova Vladislav V. Ivanchikov Aleksandra A. Rogova |
| author_facet | Eduard T. Ambarchyan Anastasiya D. Kuzminova Vladislav V. Ivanchikov Aleksandra A. Rogova |
| author_sort | Eduard T. Ambarchyan |
| collection | DOAJ |
| description | Background. Vitiligo is a depigmenting skin disease characterized by selective loss of melanocytes leading to development of typical white spots. There are various theories on vitiligo etiology: genetic, autoimmune, neurogenic, autoinflammatory, oxidative stress theory, and many others. Generally accepted dominant role is given to the concept of its autoimmune nature. Vitiligo management traditionally includes different methods of phototherapy, topical and systemic glucocorticoids (GC), and calcineurin inhibitors. Recently, Janus kinase inhibitors (JAK) have shown its efficacy in treatment of vitiligo. Clinical case description. 13-year-old male adolescent has complaints of hypopigmentation areas on the skin of face, trunk and limbs that appeared after active solar insolation during summer vacation. Dermatologist has determined a diagnosis of vitiligo according to clinical picture. Topical GC of the 3rd activity class were used for treatment, as well as course of local narrow-band medium-wave photodynamic therapy (311 nm, No. 30) with no significant effect. The patient was admitted to the dermatology department of Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery where therapy with JAK inhibitor, tofacitinib, was initiated due to inefficacy of previous treatment and the generalized form of the disease. Conclusion. Management of vitiligo with JAK inhibitors, in particular tofacitinib, is a promising method and it can lead to significant clinical effect with safety profile comparable to conventional therapies for this pathology. |
| format | Article |
| id | doaj-art-c199d878e4874c74b2bd6adf2235a0d9 |
| institution | Matheson Library |
| issn | 1682-5527 1682-5535 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | "Paediatrician" Publishers LLC |
| record_format | Article |
| series | Вопросы современной педиатрии |
| spelling | doaj-art-c199d878e4874c74b2bd6adf2235a0d92025-08-04T13:09:43Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352024-11-0123537638310.15690/vsp.v23i5.28072203Management of Generalized Vitiligo in Adolescent with Tofacitinib: Clinical CaseEduard T. Ambarchyan0Anastasiya D. Kuzminova1Vladislav V. Ivanchikov2Aleksandra A. Rogova3Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of SurgeryResearch Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of SurgeryResearch Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of SurgeryPirogov Russian National Research Medical UniversityBackground. Vitiligo is a depigmenting skin disease characterized by selective loss of melanocytes leading to development of typical white spots. There are various theories on vitiligo etiology: genetic, autoimmune, neurogenic, autoinflammatory, oxidative stress theory, and many others. Generally accepted dominant role is given to the concept of its autoimmune nature. Vitiligo management traditionally includes different methods of phototherapy, topical and systemic glucocorticoids (GC), and calcineurin inhibitors. Recently, Janus kinase inhibitors (JAK) have shown its efficacy in treatment of vitiligo. Clinical case description. 13-year-old male adolescent has complaints of hypopigmentation areas on the skin of face, trunk and limbs that appeared after active solar insolation during summer vacation. Dermatologist has determined a diagnosis of vitiligo according to clinical picture. Topical GC of the 3rd activity class were used for treatment, as well as course of local narrow-band medium-wave photodynamic therapy (311 nm, No. 30) with no significant effect. The patient was admitted to the dermatology department of Research Institute of Pediatrics and Children’s Health in Petrovsky National Research Centre of Surgery where therapy with JAK inhibitor, tofacitinib, was initiated due to inefficacy of previous treatment and the generalized form of the disease. Conclusion. Management of vitiligo with JAK inhibitors, in particular tofacitinib, is a promising method and it can lead to significant clinical effect with safety profile comparable to conventional therapies for this pathology.https://vsp.spr-journal.ru/jour/article/view/3612vitiligojak inhibitorstofacitinibchildrenadolescents |
| spellingShingle | Eduard T. Ambarchyan Anastasiya D. Kuzminova Vladislav V. Ivanchikov Aleksandra A. Rogova Management of Generalized Vitiligo in Adolescent with Tofacitinib: Clinical Case Вопросы современной педиатрии vitiligo jak inhibitors tofacitinib children adolescents |
| title | Management of Generalized Vitiligo in Adolescent with Tofacitinib: Clinical Case |
| title_full | Management of Generalized Vitiligo in Adolescent with Tofacitinib: Clinical Case |
| title_fullStr | Management of Generalized Vitiligo in Adolescent with Tofacitinib: Clinical Case |
| title_full_unstemmed | Management of Generalized Vitiligo in Adolescent with Tofacitinib: Clinical Case |
| title_short | Management of Generalized Vitiligo in Adolescent with Tofacitinib: Clinical Case |
| title_sort | management of generalized vitiligo in adolescent with tofacitinib clinical case |
| topic | vitiligo jak inhibitors tofacitinib children adolescents |
| url | https://vsp.spr-journal.ru/jour/article/view/3612 |
| work_keys_str_mv | AT eduardtambarchyan managementofgeneralizedvitiligoinadolescentwithtofacitinibclinicalcase AT anastasiyadkuzminova managementofgeneralizedvitiligoinadolescentwithtofacitinibclinicalcase AT vladislavvivanchikov managementofgeneralizedvitiligoinadolescentwithtofacitinibclinicalcase AT aleksandraarogova managementofgeneralizedvitiligoinadolescentwithtofacitinibclinicalcase |